SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Abbott launches Oncodetect molecular residual disease test

Abbott Laboratories commercially launched its Oncodetect molecular residual disease test.

ABT

Related stories